Who owns TRAWS PHARMA INC?
- Ticker: TRAW
- CUSIP Number: 68232v884
Tip: Access positions for across all investors
Analyze quarterly positions in Traws Pharma with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Traws Pharma stock
Who bought or sold TRAWS PHARMA INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Ikarian Capital | 678k | $766k | 2280% | Dec 2025 |
|
| OrbiMed Advisors | 606k | $1.1M | 0% | Sep 2025 |
|
| Adage Capital Partners GP | 330k | $611k | 0% | Sep 2025 |
|
| Boothbay Fund Management | 195k | $220k | 100% | Dec 2025 |
|
| ADAR1 Capital Management | 154k | $175k | 100% | Dec 2025 |
|
| Vanguard Group | 87k | $99k | 0% | Dec 2025 |
|
| Geode Capital Management | 62k | $70k | 42% | Dec 2025 |
|
| Seven Fleet Capital Management | 49k | $56k | 100% | Dec 2025 |
|
| XTX Topco | 42k | $48k | 294% | Dec 2025 |
|
| State Street Corporation | 26k | $29k | 100% | Dec 2025 |
|
| Two Sigma Investments | 22k | $41k | 37% | Sep 2025 |
|
| Susquehanna International | 14k | $16k | 100% | Dec 2025 |
|
| BlackRock | 10k | $11k | 0% | Dec 2025 |
|
| UBS Group | 7.7k | $9.0k | 128600% | Dec 2025 |
|
| SBI Securities | 162.00 | $300.007800 | 0% | Sep 2025 |
|
| Advisor Group Holdings | 8.00 | $9.000000 | 100% | Dec 2025 |
|
| FMR | 2.00 | $4.000000 | 0% | Sep 2025 |
|
Who sold out of Traws Pharma?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Vestal Point Capital | Sep 2025 | 150k | $278k |
| Hrt Financial | Sep 2025 | 13k | $23k |
| Raymond James Financial | Jun 2025 | 102.00 | $151.000800 |
| Vermillion & White Wealth Management Group | Sep 2025 | 96.00 | $178.003200 |
| Assetmark | Sep 2025 | 2.00 | $4.000000 |